ClinicalTrials.gov record
Completed Not applicable Interventional Results available

ADvance DBS-f in Patients With Mild Probable Alzheimer's Disease

ClinicalTrials.gov ID: NCT01608061

Public ClinicalTrials.gov record NCT01608061. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 12:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Twelve Month Double-blind Randomized Controlled Feasibility Study to Evaluate the Safety, Efficacy and Tolerability of Deep Brain Stimulation of the Fornix (DBS-f) in Patients With Mild Probable Alzheimer's Disease

Study identification

NCT ID
NCT01608061
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Functional Neuromodulation Ltd
Industry
Enrollment
42 participants

Conditions and interventions

Interventions

  • DBS-f off Device
  • DBS-f on Device

Device

Eligibility (public fields only)

Age range
45 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2012
Primary completion
May 31, 2015
Completion
Aug 31, 2018
Last update posted
Aug 30, 2020

2012 – 2018

United States locations

U.S. sites
6
U.S. states
5
U.S. cities
6
Facility City State ZIP Site status
Banner Alzheimer's Institute Phoenix Arizona 85006
Banner Research Institute at Sun City Sun City Arizona 85351
University of Florida at Gainesville Gainesville Florida 32607
Johns Hopkins Bayview Baltimore Maryland 21224
Hospital of the University of Pennsylvania: Penn Memory Clinic Philadelphia Pennsylvania 19104
Brown University Providence Rhode Island 02906

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01608061, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 30, 2020 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01608061 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →